论文部分内容阅读
新的长效抗组胺药氯雷替定氯雷替定（Ｌｏｒａｔｉｄｉｎｅ，Ｃｌａｒｉｔｉｎ－先令－普劳公司）已获ＦＤＡ批准用于减轻鼻和非鼻性季节性过敏性炎症。该药是一种长效三环抗组胺药，具有选择性拮抗组胺Ｈ１受体活性的功能。不良作用：临床试验中该药最常见的为：头痛、疲...
The new long-acting antihistamine loratadine (Loratidine, Claritin-Schilling-Prussia) has been approved by the FDA for the reduction of nasal and non-nasal seasonal allergic inflammation. This drug is a long-acting tricyclic antihistamine that selectively antagonizes histamine H1 receptor activity. Adverse effects: the most common clinical drug in the trial is: headache, fatigue ...